Source: International Congress 2019 – Translational aspects of idiopathic interstitial pneumonia
Disease area: Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
A. Averyanov (Moscow, Russian Federation), A. Sotnikova (Moscow, Russian Federation), I. Koroleva (Moscow, Russian Federation), M. Konoplyannikov (Moscow, Russian Federation), O. Danilevskaya (Moscow, Russian Federation), V. Lesnyak (Moscow, Russian Federation), V. Baklaushev (Moscow, Russian Federation). Late Breaking Abstract - High cumulative dose of allogeneic mesenchymal stem cells in patients with progressive idiopathic pulmonary fibrosis. 1297

Member's Comments

No comment yet.

Related content which might interest you: Oral presentation: Increased CXCR4 expression and short telomeres in bone marrow mesenchymal stem cells of patients with idiopathic pulmonary fibrosis Source: Lung Science Conference 2009 - Cell proliferation, Differentiation and Carcinogenesis Year: 2009 LSC - 2020 - Characterizing lung resident mesenchymal stem cells in idiopathic pulmonary fibrosis patients Source: Virtual Congress 2020 – Idiopathic pulmonary fibrosis and interstitial lung disease: progression, genes and more Year: 2020 Late Breaking Abstract - Mesenchymal stromal cells as a salvage treatment for persistent ARDS Source: Virtual Congress 2020 – New insights into mechanical ventilation in the intensive care unit Year: 2020 Late Breaking Abstract - Mesenchymal stromal cell exosomes prevent and revert experimental pulmonary fibrosis through systemic modulation of monocyte phenotypes Source: International Congress 2018 – ILDs: From bench to bedside Year: 2018 Results immunophenotyping cultured autologous mesenchymal stromal cell of patients with COPD and IPF in Belarus Source: International Congress 2015 – Latest insights into the management of chronic respiratory diseases Year: 2015 Increased CXCR4 expression and short telomeres in bone marrow mesenchymal stem cells of patients with idiopathic pulmonary fibrosis Source: Annual Congress 2009 - Pathogenesis of pulmonary fibrosis Year: 2009 Characterizing lung resident mesenchymal stem cells in idiopathic pulmonary fibrosis Source: Virtual Congress 2020 – Idiopathic pulmonary fibrosis and interstitial lung disease: progression, genes and more Year: 2020 Expression of the biological axis VEGF-CXCL12/CXCR4 in bone marrow mesenchymal stem cells (BM MSCs) in patients with idiopathic pulmonary fibrosis (IPF) Source: Annual Congress 2008 - New insights into the pathogenesis of idiopathic pulmonary fibrosis and sarcoidosis Year: 2008 Effectiveness of mesenchimal stem cells in the treatment  of patients with chronical obstructive pulmonary disease Source: International Congress 2017 – New insights into pulmonary rehabilitation in patients with chronic lung diseases Year: 2017 Low incidence of pulmonary complications following nonmyeloablative stem cell transplantation Source: Eur Respir J 2004; 23: 440-445 Year: 2004 Pulmonary infiltrates in hematopoietic stem cell trasplantation (HSCT) recipients. Associated pulmonary and systemic inflammatory response Source: Eur Respir J 2003; 22: Suppl. 45, 334s Year: 2003 LSC - 2021 - Role of mitochondrial function of lung mesenchymal stem cells in idiopathic pulmonary fibrosis Source: Virtual Congress 2021 – Advanced in vitro models for drug discovery Year: 2021 PP238 – Role of mitochondrial function of lung mesenchymal stem cells in idiopathic pulmonary fibrosis Source: ERS Lung Science Conference 2021 Year: 2021 LSC 2010 Abstract: Does cigarette smoking influence bone marrow microenvironment? Down-regulation of CXCR4 expression in bone marrow-derived mesenchymal stem cells (BM-MSCs) in patients with chronic obstructive pulmonary disease (COPD): preliminary results Source: Annual Congress 2010 - Novel mechanisms in COPD Year: 2010 Late idiopathic pneumonia syndrome after hematopoietic bone marrow transplantation: prognosis remains poor despite the use of etanercept Source: Annual Congress 2009 - Sarcoidosis and profiles of other diffuse parenchymal lung disease Year: 2009 LSC - 2021 - Modeling idiopathic pulmonary fibrosis using induced pluripotent stem cell-derived alveolar epithelial organoids Source: Virtual Congress 2021 – In vitro modelling of lung disease: reach out to the next dimension Year: 2021 Increased expression of TERT mRNA expresssion in bone marrow-derived mesenchymal stem cells (BM-MSCs) in patients with chronic obstructive pulmonary disease (COPD): Preliminary results Source: Annual Congress 2010 - Novel mechanisms in COPD Year: 2010 Effects of autologous mesenchymal stromal cell treatment for severe emphysema on lung tissue: A clinical trial Source: International Congress 2015 – The multiple facets of stem and progenitor cells in lung health and disease Year: 2015 Pirfenidone treatment in patients with bronchiolitis obliterans syndrome following allogeneic hematopoietic stem cell transplantation Source: International Congress 2016 – Orphan diseases II Year: 2016 Pulmonary alveolar proteinosis due to monocytopenia: Lung transplant or haematopoeitic stem cell transplant? Source: Annual Congress 2012 - Optimising outcomes after lung transplantation Year: 2012